Trending
Apple raised iPhone prices but may still absorb tariff costs, squeezing margins. Analysts say the company faces pressure on both sides of its pricing decision.
Real-world data shows patients who switched from injectable Wegovy to Novo’s pill kept losing weight, with major implications for pricing and competition.
Cellebrite’s 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future Rebound
Cellebrite holds a Superscore of 79 in The Motley Fool’s Hidden Gems database. Its subscription pivot is pressuring stock now, with a potential rebound framed for 2026.
The U.S. banned nearly $1 billion in Canadian imports Tuesday, including alcohol, dairy, and motorcycles, escalating already strained bilateral tensions.
J.P. Morgan says the AI trade pullback has improved investor positioning and made semiconductor valuations attractive, potentially setting up a re-engagement.
Social Security’s 2027 COLA forecast is declining as inflation cools, but retirees face rising medical and housing costs the adjustment may not cover.
Real-world data shows patients who switched from injectable Wegovy to Novo’s pill kept losing weight, with major implications for pricing and competition.
J.P. Morgan says the AI trade pullback has improved investor positioning and made semiconductor valuations attractive, potentially setting up a re-engagement.
Just In
Apple raised iPhone prices but may still absorb tariff costs, squeezing margins. Analysts say the company faces pressure on both sides of its pricing decision.
The U.S. banned nearly $1 billion in Canadian imports Tuesday, including alcohol, dairy, and motorcycles, escalating already strained bilateral tensions.
Oregon QB Dante Moore was carted off the Coliseum field in a neck brace after USC linebacker Desman Stephens hit him during a second-quarter slide.
Melania Trump and Peng Liyuan toured the Smithsonian’s National Museum of Asian Art during China’s diplomatic visit to Washington, framing U.S.-China ties around culture.
Finance
Cellebrite’s 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future Rebound
Cellebrite holds a Superscore of 79 in The Motley Fool’s Hidden Gems database. Its subscription pivot is pressuring stock now, with a potential rebound framed for 2026.
Editor's Picks
The 30-year Treasury yield hit its highest level since 2004 on Thursday, extending a months-long bond selloff that is raising US borrowing costs sharply.
Latest
BigBear.ai has locked-in government customers. QuantumScape is still proving its battery tech works. Both are unprofitable — but the risks are nothing alike.
































